Azora Therapeutics, Inc. (DE) AZR
NASDAQ AZR
$4.09 +0.35 (+9.36%)
At close: Nov 13, 2026 · 4:00 PM EST

Azora Therapeutics, Inc. (DE) (AZR) Change in Accrued Expenses (2017 - 2026)

Updated

Azora Therapeutics, Inc. (DE) (AZR) recorded Change in Accrued Expenses of $1.17 million in Q3 2026, compared with $94,000 a year earlier.

Analysis

Azora Therapeutics, Inc. (DE) (AZR) Change in Accrued Expenses (2017 - 2026) Analysis & Trends

On a TTM basis, Azora Therapeutics, Inc. (DE)'s Change in Accrued Expenses came in at -$737,923 as of Sep 30, 2026; for FY2025, it came in at $405,077, up 102.8% from FY2024.

  • Annual Change in Accrued Expenses has a five-year compound annual growth rate of -2.4% (FY2020 to FY2025).
  • Across earlier years, Change in Accrued Expenses came in at $199,709 in FY2024, -$485,580 in FY2023, -$1.41 million in FY2022 and $1.52 million in FY2021 (+231.6%).
  • The Q3 2026 figure is the highest quarterly Change in Accrued Expenses in data going back to Q3 2017.
  • On a year-over-year basis, Change in Accrued Expenses rose in three of the last four quarters, with growth averaging 101.4%.
  • Per Business Quant, the preceding three quarters came in at -$2.55 million (Q2 2026), $194,802 (Q1 2026) and $448,077 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.41 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 983.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 756.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Azora Therapeutics, Inc. (DE) 58.43 Mn -2.79 Mn - 1.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.17 Mn
Jun 30, 2026 -2.55 Mn
Mar 31, 2026 194,802.00
Dec 31, 2025 448,011.00
Sep 30, 2025 94,066.00
Jun 30, 2025 -218,239.00
Mar 31, 2025 81,239.00
Dec 31, 2024 176,528.00
Sep 30, 2024 165,772.00
Jun 30, 2024 -40,107.00
Mar 31, 2024 -102,484.00
Dec 31, 2023 69,133.00
Sep 30, 2023 84,203.00
Jun 30, 2023 -822,637.00
Mar 31, 2023 183,721.00
Dec 31, 2022 110,082.00
Sep 30, 2022 -66,608.00
Jun 30, 2022 -774,978.00
Mar 31, 2022 -682,099.00
Dec 31, 2021 652,091.00
API Access

Azora Therapeutics, Inc. (DE) Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=AZR&period=max&api_key=YOUR_API_KEY